Pulse Biosciences, Inc. (PLSE)
50.44
-1.81
(-3.46%)
USD |
NASDAQ |
Nov 13, 16:00
50.25
-0.19
(-0.38%)
After-Hours: 19:59
Pulse Biosciences Enterprise Value : 3.515B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.515B |
| November 12, 2026 | 3.648B |
| November 11, 2026 | 3.995B |
| November 10, 2026 | 3.858B |
| November 09, 2026 | 4.082B |
| November 06, 2026 | 3.724B |
| November 05, 2026 | 3.708B |
| November 04, 2026 | 4.001B |
| November 03, 2026 | 3.644B |
| November 02, 2026 | 3.696B |
| October 30, 2026 | 3.647B |
| October 29, 2026 | 3.885B |
| October 28, 2026 | 3.752B |
| October 27, 2026 | 3.718B |
| October 26, 2026 | 3.678B |
| October 23, 2026 | 3.704B |
| October 22, 2026 | 3.679B |
| October 21, 2026 | 3.579B |
| October 20, 2026 | 3.544B |
| October 19, 2026 | 3.303B |
| October 16, 2026 | 3.075B |
| October 15, 2026 | 3.160B |
| October 14, 2026 | 3.213B |
| October 13, 2026 | 3.376B |
| October 12, 2026 | 3.663B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.762B |
| October 08, 2026 | 3.481B |
| October 07, 2026 | 3.416B |
| October 06, 2026 | 3.465B |
| October 05, 2026 | 3.520B |
| October 02, 2026 | 3.329B |
| October 01, 2026 | 3.470B |
| September 30, 2026 | 3.477B |
| September 29, 2026 | 3.508B |
| September 28, 2026 | 3.609B |
| September 25, 2026 | 3.561B |
| September 24, 2026 | 3.575B |
| September 23, 2026 | 3.585B |
| September 22, 2026 | 3.636B |
| September 21, 2026 | 3.680B |
| September 18, 2026 | 3.719B |
| September 17, 2026 | 3.488B |
| September 16, 2026 | 3.418B |
| September 15, 2026 | 3.813B |
| September 14, 2026 | 3.743B |
| September 11, 2026 | 3.665B |
| September 10, 2026 | 3.759B |
| September 09, 2026 | 3.655B |
| September 08, 2026 | 3.359B |
| September 04, 2026 | 3.675B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 101.26M |
| Orthofix Medical, Inc. | 467.34M |
| ResMed, Inc. | 33.27B |
| Rockwell Medical, Inc. | 18.92M |
| Microbot Medical, Inc. | -1.771M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.05M |
| Revenue (Quarterly) | 0.395M |
| Total Expenses (Quarterly) | 23.45M |
| EPS Diluted (Quarterly) | -0.3205 |
| Gross Profit Margin (Quarterly) | 18.61% |
| Profit Margin (Quarterly) | -5.84K% |
| Earnings Yield | -2.39% |
| Normalized Earnings Yield | -2.393 |